Press Release: Sept. 30, 2022 – Utrecht, the Netherlands
We are delighted to welcome Nitin as a seed investor and Chief Corporate Development Officer of Keystonemab. Nitin will actively help with developing Keystonemab’s corporate strategy and business relationships in high growth market including India. Nitin is a serial entrepreneur with focus on industrial real-estate since last 30 years. He is also active in ‘high growth pharmaceutical CDMO investment space’ since 2019.
Nitin will help to identify and develop partners network in Asia who are interested in developing differentiated products for regulated market using Keystonemab technology.